These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 19366853)
1. Serum chromogranin A concentration in hyperthyroidism before and after medical treatment. Al-Shoumer KA; Vasanthy BA J Clin Endocrinol Metab; 2009 Jul; 94(7):2321-4. PubMed ID: 19366853 [TBL] [Abstract][Full Text] [Related]
2. Effects of treatment of hyperthyroidism on glucose homeostasis, insulin secretion, and markers of bone turnover. Al-Shoumer KA; Vasanthy BA; Al-Zaid MM Endocr Pract; 2006; 12(2):121-30. PubMed ID: 16690458 [TBL] [Abstract][Full Text] [Related]
3. Change of visfatin, C-reactive protein concentrations, and insulin sensitivity in patients with hyperthyroidism. Chu CH; Lee JK; Wang MC; Lu CC; Sun CC; Chuang MJ; Lam HC Metabolism; 2008 Oct; 57(10):1380-3. PubMed ID: 18803942 [TBL] [Abstract][Full Text] [Related]
4. Effects of different treatments for hyperthyroidism on the hypothalamic-pituitary-adrenal axis. Lizcano F; Salvador J Clin Exp Pharmacol Physiol; 2008 Sep; 35(9):1085-90. PubMed ID: 18505442 [TBL] [Abstract][Full Text] [Related]
5. Plasma levels of resistin and ghrelin before and after treatment in patients with hyperthyroidism. El Gawad SS; El Kenawy F; Mousa AA; Omar AA Endocr Pract; 2012; 18(3):376-81. PubMed ID: 21742599 [TBL] [Abstract][Full Text] [Related]
6. Plasma adrenocorticotropin (ACTH) values and cortisol response to 250 and 1 microg ACTH stimulation in patients with hyperthyroidism before and after carbimazole therapy: case-control comparative study. Mishra SK; Gupta N; Goswami R J Clin Endocrinol Metab; 2007 May; 92(5):1693-6. PubMed ID: 17327382 [TBL] [Abstract][Full Text] [Related]
7. Cardiovascular manifestations of hyperthyroidism before and after antithyroid therapy: a matched case-control study. Osman F; Franklyn JA; Holder RL; Sheppard MC; Gammage MD J Am Coll Cardiol; 2007 Jan; 49(1):71-81. PubMed ID: 17207725 [TBL] [Abstract][Full Text] [Related]
8. Association of serum paraoxonase activity with insulin sensitivity and oxidative stress in hyperthyroid and TSH-suppressed nodular goitre patients. Yavuz DG; Yüksel M; Deyneli O; Ozen Y; Aydin H; Akalin S Clin Endocrinol (Oxf); 2004 Oct; 61(4):515-21. PubMed ID: 15473886 [TBL] [Abstract][Full Text] [Related]
9. Weight homeostasis & its modulators in hyperthyroidism before & after treatment with carbimazole. Dutta P; Bhansali A; Walia R; Khandelwal N; Das S; Masoodi SR Indian J Med Res; 2012 Aug; 136(2):242-8. PubMed ID: 22960891 [TBL] [Abstract][Full Text] [Related]
10. Lack of effect of thyroxine in patients with Graves' hyperthyroidism who are treated with an antithyroid drug. McIver B; Rae P; Beckett G; Wilkinson E; Gold A; Toft A N Engl J Med; 1996 Jan; 334(4):220-4. PubMed ID: 8531998 [TBL] [Abstract][Full Text] [Related]
11. Serum fructosamine concentration in cats with overt hyperthyroidism. Reusch CE; Tomsa K J Am Vet Med Assoc; 1999 Nov; 215(9):1297-300. PubMed ID: 10553441 [TBL] [Abstract][Full Text] [Related]
12. Iopanoic acid as an adjunct to carbimazole in the management of hyperthyroidism. Gupta SK; Mithal A; Godbole MM Natl Med J India; 1992; 5(3):108-11. PubMed ID: 1304283 [TBL] [Abstract][Full Text] [Related]
13. Bone mineral density trends in Indian patients with hyperthyroidism--effect of antithyroid therapy. Dhanwal DK; Gupta N J Assoc Physicians India; 2011 Sep; 59():561-2, 567. PubMed ID: 22334969 [TBL] [Abstract][Full Text] [Related]
14. Changes in parameters of bone and mineral metabolism during therapy for hyperthyroidism. Pantazi H; Papapetrou PD J Clin Endocrinol Metab; 2000 Mar; 85(3):1099-106. PubMed ID: 10720046 [TBL] [Abstract][Full Text] [Related]